These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 35233113)

  • 41. Epidemiological profile of SARS-CoV-2 among selected regions in Ghana: A cross-sectional retrospective study.
    Owusu M; Sylverken AA; Ankrah ST; El-Duah P; Ayisi-Boateng NK; Yeboah R; Gorman R; Asamoah J; Binger T; Acheampong G; Bekoe FA; Ohene SA; Larsen-Reindorf R; Awuah AA; Amuasi J; Owusu-Dabo E; Adu-Sarkodie Y; Phillips RO
    PLoS One; 2020; 15(12):e0243711. PubMed ID: 33301533
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Laboratory preparedness for SARS-CoV-2 testing in India: Harnessing a network of Virus Research & Diagnostic Laboratories.
    Gupta N; Potdar V; Praharaj I; Giri S; Sapkal G; Yadav P; Choudhary ML; Dar L; Sugunan AP; Kaur H; Munivenkatappa A; Shastri J; Kaveri K; Dutta S; Malhotra B; Jain A; Nagamani K; Shantala GB; Raut S; Vegad MM; Sharma A; Choudhary A; Brijwal M; Balakrishnan A; Manjunatha J; Pathak M; Srinivasan S; Banu H; Sharma H; Jain P; Sunita P; Ambica R; Fageria B; Patel D; Rajbongshi G; Vijay N; Narayan J; Aggarwal N; Nagar A; Gangakhedkar RR; Abraham P
    Indian J Med Res; 2020 Feb & Mar; 151(2 & 3):216-225. PubMed ID: 32242875
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The first laboratory-confirmed imported infections of SARS-CoV-2 in Sudan.
    Aljak ER; Eldigail M; Mahmoud I; Elhassan RM; Elduma A; Ibrahim AA; Ali Y; Weaver SC; Ahmed A
    Trans R Soc Trop Med Hyg; 2021 Jan; 115(1):103-109. PubMed ID: 33319246
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Status of COVID-19 vaccination around South Asia.
    Hayat M; Uzair M; Ali Syed R; Arshad M; Bashir S
    Hum Vaccin Immunother; 2022 Dec; 18(1):2016010. PubMed ID: 35061956
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of Nigeria Presidential Task Force on COVID-19 Pandemic, Nigeria.
    Bolu O; Mustapha B; Ihekweazu C; Muhammad M; Hassan A; Abdulwahab A; Asekun AA; Nsirim R; Okechukwu E; Attah I; Swaminathan M; Greby S; Adebiyi A; Alex-Okoh M; Okwor T; Ilori E; Mba N; Mutah J; Akujobi J; Battah N; Haggai W; Okatubo G; Okigbo A; Castle E; Abubakar I; Akataobi C; Adekunle O; Aliyu SH
    Emerg Infect Dis; 2022 Dec; 28(13):S168-S176. PubMed ID: 36502390
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A Reminder of Skin Cancer During the COVID-19 Pandemic.
    Šitum M; Filipović N; Buljan M
    Acta Dermatovenerol Croat; 2021 Apr; 291(1):58. PubMed ID: 34477068
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Systematic Review of Clinical Insights into Novel Coronavirus (CoVID-19) Pandemic: Persisting Challenges in U.S. Rural Population.
    Lakhani HV; Pillai SS; Zehra M; Sharma I; Sodhi K
    Int J Environ Res Public Health; 2020 Jun; 17(12):. PubMed ID: 32549334
    [TBL] [Abstract][Full Text] [Related]  

  • 48. COVID-19, Australia: Epidemiology Report 19 (Fortnightly reporting period ending 21 June 2020).
    COVID-19 National Incident Room Surveillance Team
    Commun Dis Intell (2018); 2020 Jun; 44():. PubMed ID: 32600222
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Person-centred innovations for family medicine and COVID-19 in Ghana: A short report.
    Darko DO
    Afr J Prim Health Care Fam Med; 2021 Aug; 13(1):e1-e4. PubMed ID: 34476970
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Insights into COVID-19 Vaccine Development Based on Immunogenic Structural Proteins of SARS-CoV-2, Host Immune Responses, and Herd Immunity.
    Chaudhary JK; Yadav R; Chaudhary PK; Maurya A; Kant N; Rugaie OA; Haokip HR; Yadav D; Roshan R; Prasad R; Chatrath A; Singh D; Jain N; Dhamija P
    Cells; 2021 Oct; 10(11):. PubMed ID: 34831172
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Beyond SARS-CoV-2: Lessons That African Governments Can Apply in Preparation for Possible Future Epidemics.
    Oboh MA; Omoleke SA; Imafidon CE; Ajibola O; Oriero EC; Amambua-Ngwa A
    J Prev Med Public Health; 2020 Sep; 53(5):307-310. PubMed ID: 33070501
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prevalence of pneumonia by chest x-ray, associated demographic characteristics and health risk factors among COVID-19 patients in Ghana.
    Oliver-Commey JA; Puplampu P; Owoo C; Asare-Boateng K; Yawson AO; Tetteh J; Calys-Tagoe BNL; Udofia E; Kenu E; Samba A; Yawson AE; Lartey M;
    Ghana Med J; 2021 Jun; 55(2 Suppl):21-28. PubMed ID: 35233111
    [TBL] [Abstract][Full Text] [Related]  

  • 53. An evaluation of COVID-19 surveillance system in New Juaben South Municipality of Ghana: a cross-sectional study.
    Awekeya H; Dubik SD; Amegah K; Ashinyo A; Wuobar F; Kaitoo E; Ofosu W; Ashinyo ME
    Pan Afr Med J; 2021; 40():206. PubMed ID: 35136469
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Does the data tell the true story? A modelling assessment of early COVID-19 pandemic suppression and mitigation strategies in Ghana.
    Frempong NK; Acheampong T; Apenteng OO; Nakua E; Amuasi JH
    PLoS One; 2021; 16(10):e0258164. PubMed ID: 34714857
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pandemic preparedness and response to COVID-19 in South Asian countries.
    Babu GR; Khetrapal S; John DA; Deepa R; Narayan KMV
    Int J Infect Dis; 2021 Mar; 104():169-174. PubMed ID: 33370566
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The Impact of COVID-19 and Religious Restrictions on the Well-Being of Ghanaian Christians: The Perspectives of Religious Leaders.
    Osei-Tutu A; Affram AA; Mensah-Sarbah C; Dzokoto VA; Adams G
    J Relig Health; 2021 Aug; 60(4):2232-2249. PubMed ID: 34014473
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Social distancing policies in 22 African countries during the COVID-19 pandemic: a desk review.
    Verani A; Clodfelter C; Menon AN; Chevinsky J; Victory K; Hakim A
    Pan Afr Med J; 2020; 37(Suppl 1):46. PubMed ID: 33552374
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Australian critical care nurses' knowledge, preparedness, and experiences of managing SARS-COV-2 and COVID-19 pandemic.
    Nahidi S; Sotomayor-Castillo C; Li C; Currey J; Elliott R; Shaban RZ
    Aust Crit Care; 2022 Jan; 35(1):22-27. PubMed ID: 34462194
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
    Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
    Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Consensus summary report for CEPI/BC March 12-13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines.
    Lambert PH; Ambrosino DM; Andersen SR; Baric RS; Black SB; Chen RT; Dekker CL; Didierlaurent AM; Graham BS; Martin SD; Molrine DC; Perlman S; Picard-Fraser PA; Pollard AJ; Qin C; Subbarao K; Cramer JP
    Vaccine; 2020 Jun; 38(31):4783-4791. PubMed ID: 32507409
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.